The Liver Meeting 2019-Precision Therapy in Patients with Primary Biliary Cholangitis*

Precision Therapy in Patients with Primary Biliary Cholangitis*

Video Transcription

Video Summary

The speaker discusses a case of a 61-year-old woman with primary biliary cholangitis (PBC), detailing her treatment journey and the importance of monitoring responses. They explore treatment options including FXR ligands, PPAR ligands, and glucocorticoid receptor ligands. The significance of biochemical response assessment is emphasized using various criteria, with a focus on early-stage PBC and response prediction tools. The speaker also delves into the role of antinuclear antibodies in diagnosis and prognosis, as well as addressing the management of symptoms such as fatigue and pruritus in PBC patients. Lastly, they touch on the importance of tailoring second-line therapy based on individual patient profiles and symptom management.

Asset Caption

Presenter: Michael Trauner

Keywords

primary biliary cholangitis

treatment journey

FXR ligands

biochemical response assessment

antinuclear antibodies